Helicobacter pylori
Dormancy period: Up to the lifetime of the patient.
Gastric disorders due to infection begin with gastritis, inflammation of the stomach lining. When infection is persistent the prolonged inflammation will become chronic gastritis. Initially this will be non-atrophic gastritis, but damage caused to the stomach lining can bring about the change to atrophic gastritis, and the development of ulcers both within the stomach itself or in the duodenum, the nearest part of the intestine.
Helicobacter pylori is a class 1 carcinogen, and potential cancers include gastric mucosa-associated lymphoid tissue (MALT) lymphomas and gastric cancer. Infection with H. pylori is responsible for around 89 per cent of all gastric cancers, and is linked to the development of 5.5 per cent of all cases of cancer worldwide. H. pylori is the only bacterium known to cause cancer. Most people infected with H. pylori never experience any symptoms or complications, but will have a 10% to 20% risk of developing peptic ulcers or a 0.5% to 2% risk of stomach cancer. It was estimated that about two-thirds of the world’s population were infected with H. pylori, being more common in developing countries.
An infection with Helicobacter pylori can either have no symptoms even when lasting a lifetime, or can harm the stomach and duodenal linings by inflammatory responses induced by several mechanisms associated with a number of virulence factors.
https://en.wikipedia.org/wiki/Helicobacter_pylori
https://duckduckgo.com/?q=%22Helicobacter+pylori%22&t=ftsa&iar=images&iax=images&ia=images
Therapure Remedies: CP ABO, PAR-D, CP PAR-M, CP W, Neem Soap,
Jamu Jo: JJ 6, 8, 10, 11, 13, 14, 15.
IV Therapy: Glutathione, DMSO, CP ID, CP IN, CP IZ, CP IS, Lysine, Magnesium, Vitamin B Complex, Vitamin D, Zinc.
Conventional Remedies: Proton-pump inhibitor, amoxicillin, clarithromycin, metronidazole, tetracycline.